Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wehling

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysisC Wehling, M Kirschfink
Critical Care Medicine|September 1, 1985
Pseudodysrhythmia during dialysisC E Bartecchi, C Wehling
Pathology|January 1, 1977
Diagnosis of Batten disease from urinary sediment: a brief reportD Armstrong, C Wehling, D V Wormer
Hospital & Community Psychiatry|September 1, 1987
Group art therapy as an adjunct to treatment for chronic outpatientsB L Green, C Wehling, G J Talsky
Investigative Ophthalmology & Visual Science|January 1, 1980
Studies on the retina and the pigment epithelium in hereditary canine ceroid lipofuscinosis. III. Morphologic abnormalities in retinal neurons and retinal pigmented epithelial cellsH Neville, D Armstrong, B Wilson, et al.
Neurochemistry International|May 22, 2010
Morphological and biochemical abnormalities in a model of retinal degeneration: Canine ceroid-lipofuscinosis (CCL)D Armstrong, H Neville, A Siakotos, et al.
Journal of the American Medical Directors Association|July 21, 2021
Student Led Window Art Intervention to Support Long Term Care Facilities During the COVID-19 PandemicDaina Keehn, D Keehn, M Nordeen, et al.
Archives of Neurology|March 1, 1982
Sjögren's syndrome and polymyositis or dermatomyositisS P Ringel, J Z Forstot, E M Tan, et al.
Familial Cancer|November 4, 2025
Endoscopic papillectomy for ampullary adenomas in familial adenomatous polyposisC Wehling, Y Eckstein, A Stenzinger, et al.
Clinical and Experimental Immunology|October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disordersC Wehling, O Amon, M Bommer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysisC Wehling, M Kirschfink
Critical Care Medicine|September 1, 1985
Pseudodysrhythmia during dialysisC E Bartecchi, C Wehling
Pathology|January 1, 1977
Diagnosis of Batten disease from urinary sediment: a brief reportD Armstrong, C Wehling, D V Wormer
Hospital & Community Psychiatry|September 1, 1987
Group art therapy as an adjunct to treatment for chronic outpatientsB L Green, C Wehling, G J Talsky
Investigative Ophthalmology & Visual Science|January 1, 1980
Studies on the retina and the pigment epithelium in hereditary canine ceroid lipofuscinosis. III. Morphologic abnormalities in retinal neurons and retinal pigmented epithelial cellsH Neville, D Armstrong, B Wilson, et al.
Neurochemistry International|May 22, 2010
Morphological and biochemical abnormalities in a model of retinal degeneration: Canine ceroid-lipofuscinosis (CCL)D Armstrong, H Neville, A Siakotos, et al.
Journal of the American Medical Directors Association|July 21, 2021
Student Led Window Art Intervention to Support Long Term Care Facilities During the COVID-19 PandemicDaina Keehn, D Keehn, M Nordeen, et al.
Archives of Neurology|March 1, 1982
Sjögren's syndrome and polymyositis or dermatomyositisS P Ringel, J Z Forstot, E M Tan, et al.
Familial Cancer|November 4, 2025
Endoscopic papillectomy for ampullary adenomas in familial adenomatous polyposisC Wehling, Y Eckstein, A Stenzinger, et al.
Clinical and Experimental Immunology|October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disordersC Wehling, O Amon, M Bommer, et al.
Pageof 2